Genetics and protein content decide whether a ketogenic diet slims or fattens mice
In mice, the same ketogenic diet caused weight loss or fat gain depending on protein content and strain genetics, driven by GDF15 and LCN2 signaling.
Summary
A ketogenic diet is often assumed to curb appetite and body weight. This mouse study from Rockefeller University shows the result depends on two things: how much protein the diet contains and the animal's genetic background. In one common lab strain (C57BL/6J), a ketogenic diet with 5% protein cut food intake, caused weight loss and lowered blood sugar. The same diet with 10% protein instead increased body fat and impaired glucose tolerance. A closely related strain (C57BL/6NJ) did not respond the same way. The weight loss ran through two stress-related hormones, GDF15 and LCN2, acting on a brain pathway involving GFRAL neurons. Mutations in the genes Nnt and Nlrp12 helped explain the strain difference. The antioxidant N-acetylcysteine lowered these hormones and blunted weight loss. This is mouse work only, so it does not show how people will respond, though the authors suggest similar factors may matter in humans.
Detailed Summary
Why this matters: Ketogenic diets are popular for weight control and metabolic health, yet individual responses vary widely and are poorly explained. High-fat diets usually promote overeating and obesity, while ketogenic diets often suppress appetite. Understanding what flips that response could help explain why some people thrive on keto and others do not.
What was studied: Researchers at Rockefeller University compared two ketogenic diets in mice, one with 5% protein (KD-5%P) and one with 10% protein (KD-10%P). They used two near-identical substrains, C57BL/6J (B6J) and C57BL/6NJ (B6NJ), which differ in a handful of genes. Mechanistic experiments included neuron ablation, gene re-expression, knockouts and a drug intervention.
Key results: In B6J mice, KD-5%P caused reduced food intake, weight loss and low blood sugar, whereas KD-10%P increased adiposity and glucose intolerance. B6NJ mice did not show the weight-loss response. KD-5%P raised the circulating hormones GDF15 and LCN2 in B6J mice, and ablating GFRAL neurons, the brain receptor cells for GDF15, blunted weight loss. B6J mice carry mutations in Nnt and Nlrp12. Restoring NNT in the liver mitigated weight loss, with a trend toward lower GDF15. Knocking out Nlrp12 in B6NJ mice caused weight loss and higher LCN2, and combined Nlrp12/Nnt knockout moved B6NJ responses toward those of B6J. KD-5%P also produced liver stress and inflammation in B6J mice, and N-acetylcysteine lowered GDF15 and LCN2 and attenuated weight loss.
Implications: Protein content and genetics together determine whether a ketogenic diet suppresses appetite through a stress-hormone axis or promotes fat gain. The weight loss here was tied to hepatic stress, so it should not be read as a purely beneficial effect.
Caveats: This is mouse work, the abstract does not report lifespan or human data, and the human relevance is only suggested by the authors. Details such as group sizes were not available.
Key Findings
- In B6J mice, a 5% protein ketogenic diet caused reduced food intake, weight loss and hypoglycemia; B6NJ mice did not respond this way.
- The same diet with 10% protein increased adiposity and glucose intolerance in B6J mice, reversing the direction of effect.
- GDF15 and LCN2 rose on KD-5%P, and GFRAL-neuron ablation blunted weight loss, implicating a brain-mediated stress-hormone pathway.
- Nnt and Nlrp12 mutations contributed to the strain difference; combined Nlrp12/Nnt knockout shifted B6NJ toward the B6J response.
- KD-5%P caused hepatic stress and inflammation; N-acetylcysteine lowered GDF15 and LCN2 and attenuated weight loss.
Methodology
Controlled mouse experiments compared two ketogenic diets (5% vs 10% protein) across C57BL/6J and C57BL/6NJ substrains. Causality was probed with GFRAL-neuron ablation, hepatic NNT re-expression, Nlrp12 and Nnt knockouts, and N-acetylcysteine treatment. Mechanism and body-weight/metabolic function were assessed; no lifespan outcome is reported in the abstract.
Study Limitations
This summary is based on the abstract only, so sample sizes, sex, duration and statistics were not available. The work is in mice, with strain-specific mutations that may not map onto human genetic variation, and weight loss was accompanied by liver stress and inflammation. The Nnt effect on GDF15 was only a trend, and no lifespan or human data are reported.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
